MedTrace Logo

Utility of Sodium Lactate Infusion During Septic Shock

NCT03528213 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2025-12-11

No results posted yet for this study

Summary

ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid balance in septic shock patients

Conditions

  • Septic Shock

Interventions

DRUG

Sodium Lactate light dose

bolus 2.5ml/kg then 0.25ml/kg/h

DRUG

Sodium Lactate high dose

bolus 2.5ml/kg then 0.5ml/kg/h

DRUG

Normal saline

normal saline at physician discretion

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Raphaël Favory, MD,PhD · University Hospital, Lille

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-04
Primary Completion
2023-02-21
Completion
2023-02-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03528213 on ClinicalTrials.gov